Sanofi (SNY) EBITDA Margin (QoQ) (2009 - 2026)
Sanofi (SNY) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.77 Bn | 632.01 Bn | 17.26 Bn |
| 2 | AbbVie | 469.90 Bn | 463.33 Bn | 12.70 Bn |
| 3 | Merck | 377.04 Bn | 369.90 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.08 Bn | 295.39 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.74 Bn | 252.84 Bn | 12.86 Bn |
| 6 | Amgen | 236.46 Bn | 222.47 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.81 Bn | 178.63 Bn | 6.22 Bn |
| 8 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn |
| 9 | Gsk | 106.28 Bn | 102.11 Bn | 8.24 Bn |
| 10 | Sanofi | 55.01 Bn | 47.63 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 466.00 |
| Mar 31, 2026 | 23,673.00 |
| Dec 31, 2025 | -23,705.00 |
| Sep 30, 2025 | -321.00 |
| Jun 30, 2025 | 72.00 |
| Mar 31, 2025 | -22,224.00 |
| Dec 31, 2024 | 23,116.00 |
| Sep 30, 2024 | -713.00 |
| Jun 30, 2024 | -104.00 |
| Mar 31, 2024 | 48.00 |
| Dec 31, 2023 | 800.00 |
| Sep 30, 2023 | -711.00 |
| Jun 30, 2023 | -35.00 |
| Mar 31, 2023 | -498.00 |
| Dec 31, 2022 | 1,227.00 |
| Sep 30, 2022 | -624.00 |
| Jun 30, 2022 | 176.00 |
| Mar 31, 2022 | 291.00 |
| Dec 31, 2021 | 291.00 |
| Sep 30, 2021 | -513.00 |